Business Context and Reporting Period
This Form 6-K filing by Eason Technology Limited (Eason Technology) covers the month of May 2025. The report addresses a regulatory notice received on May 16, 2025, from NYSE Regulation regarding the Company's non-compliance with continued listing standards on NYSE American.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on regulatory compliance status rather than financial performance data.
Material Changes
The primary material change is the Company's failure to timely file its Form 20-F for the fiscal year ended December 31, 2024, by the May 15, 2025 deadline. This filing delinquency was previously disclosed in a Form 12b-25 filed on April 30, 2025, citing delays in completing financial statements.
Outlook, Risks, and Management Commentary
- Cure Periods: NYSE American has established an "Initial Cure Period" of six months (until November 15, 2025) to resolve the delinquency. If unresolved, the Exchange may grant an "Additional Cure Period" of up to six months (until May 15, 2026).
- Delisting Risk: Failure to cure the delinquency within the applicable cure period(s) will likely result in the commencement of suspension and delisting procedures.
- Current Trading Status: The Company's ADSs will continue to be listed and traded on NYSE American during the cure period, subject to compliance with other listing requirements.
- Management Action: Management states it is making all efforts to file the 2024 Form 20-F as soon as possible but offers no assurance of regaining full compliance.
Investor Verification Checklist
- Verify the expected filing date for the overdue 2024 Form 20-F.
- Monitor the Company's status regarding the "Initial Cure Period" deadline of November 15, 2025.
- Review the attached press release (Exhibit 99.1) for additional details on the delay in financial statement completion.
- Assess the risk of potential suspension or delisting if the filing is not completed within the specified cure periods.